Pradaxa is a blood-thinning medication prescribed to reduce the risk of stroke in those with atrial fibrillation (irregular heartbeat). Pradaxa (dabigatran etexilate mesylate) is made by Boehringer Ingelheim and was approved by the U.S. Food and Drug Administration (FDA) in October 2010.1
Despite its efficacy at preventing the formation of blood clots, Pradaxa has been linked to some serious side effects, including life-threatening, uncontrollable bleeding events.
If you or a loved one has suffered a serious Pradaxa complication, you can turn to the experienced drug injury attorneys at the Amaro Law Firm for advocacy, personal service, and compassion in the pursuit of justice and financial recovery.
At the Amaro Law Firm, our lawyers are dedicated advocates for those who have been injured by risky and dangerous drugs, like Pradaxa. Strategic and relentless, we are ready to help you determine if you have a claim and, if so, successfully navigate the recovery process. While we recognize that compensation cannot erase the permanent losses caused by Pradaxa complications, we are also aware that these recoveries can be vital to healing and restoring lives.
Have You or a Loved One Suffered Serious Pradaxa Complications?
Call (713) 352-7975, Text (281) 612-8024 or Contact Our Firm
for a FREE, No Obligations Consultation
During your FREE consultation, we will review your potential claim and explain your legal options. We represent clients from across the U.S. in drug injury claims, and we offer free virtual and mobile consultations to anyone who is unable to visit our offices.
Background: How Pradaxa Works
Intended to replace warfarin, Pradaxa is part of a new class of anticoagulant drugs (that also includes Xarelto and Eliquis). Pradaxa limits the liver’s production of vitamin K, which is necessary for blood clotting. As a result, Pradaxa prevents blood clots from forming and reduces the risk of clot-related complications, like (but not limited to):
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
In addition to being prescribed to patients with atrial fibrillation, Pradaxa is also prescribed to those at risk of DVT, PE, or stroke, including patients who have recently undergone a knee or hip replacement surgery.
Common, milder side effects of Pradaxa may include (and may not be limited to):
- Abdominal pain
- Bruising easily
Pradaxa Bleeding Events
The most serious complication associated with Pradaxa is sudden, uncontrollable bleeding events:
Praxada bleeding events are most likely to involve gastrointestinal (GI) hemorrhaging. The antidote for Pradaxa bleeding, Praxbind, is also manufactured by Boehringer Ingelheim.
The labeling and medication guides for Pradaxa include black box warnings regarding the serious risks of bleeding events. As the most serious type of FDA warning, black box warnings indicate a drug’s potential to cause fatal complications.
Other Serious Pradaxa Complications
Along with hemorrhaging, other serious complications that have been linked to Pradaxa include (but may not be exclusive to):
- Heart attack – A 2012 study found that Pradaxa patients have a 33 percent higher risk of suffering a heart attack or developing severe heart disease symptoms when compared to warfarin patients.2
- Spinal hematomas – Pradaxa patients who receive a spinal injection (like an epidural) have an increased risk of developing a hematoma at the injection site. This causes the pooling of blood, which can result in long-term or irreversible paralysis.
- Liver and kidney complications – Liver failure and kidney failure have also been linked to Pradaxa use. Researchers are still investigating these risks.
Pradaxa Lawsuits & Multidistrict Litigation (MDL)
Thousands of Pradaxa lawsuits have been filed in state and federal courts across the U.S., and drug companies have already paid out hundreds of millions of dollars to settle some of these cases. These claims generally allege that:
- The anticoagulant drug caused patients to develop serious, if not potentially deadly, complications.
- The drug companies failed to:
- Properly test the safety of Pradaxa before bringing it to market
- Warn the public about the serious risks associated with Pradaxa
- Establish and provide protocols for treating Pradaxa bleeding events.
The increasing number of Pradaxa lawsuits filed by plaintiffs nationwide has led the Judicial Panel on Multidistrict Litigation (JPML) to issue a transfer order, establishing a Pradaxa MDL (MDL No. 2385), based in the U.S. District Court, Southern District of Illinois.3
Those who have a new Pradaxa claim may join the ongoing MDL or pursue an individual claim. The best option for a given plaintiff and case will depend on the details of the claim, as well as the needs and objectives of the prospective plaintiff.
An attorney at the Amaro Law Firm can explain your options and get you on the path to recovery and justice.
Get Answers about Your Potential Claim: Contact a Dangerous Drug Lawyer at the Amaro Law Firm
If you or someone you love has been seriously harmed by Pradaxa, it is time to contact an experienced dangerous drug lawyer at the Amaro Law Firm.
With more than 20 years’ legal experience, our attorneys have the insight, dedication, and skills to effectively represent you in any legal setting and to bring your claim to the best possible outcome.